PD-L1, PD-L2, THY1, and SPP1 from tumor or immune-inhibited cells play a central role in inhibiting the function of CD8_Tpex and CD8_Tex cells during anti-tumor immunity. The gene discussed is THY1; the disease is neoplasm.